Evidence map›Paper›PMID 27943045›Full record

ArticleClinical rheumatology2017

The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients.

Brooke Levis, Linda Kwakkenbos, Marie Hudson, Murray Baron, Brett D Thombs, and the Canadian Scleroderma Research Group

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Brooke LevisLady Davis Institute for Medical Research, Jewish General Hospital, 4333 Cote St Catherine Road, Montréal, Québec, H3T 1E4, Canada.
Linda KwakkenbosLady Davis Institute for Medical Research, Jewish General Hospital, 4333 Cote St Catherine Road, Montréal, Québec, H3T 1E4, Canada.
Marie HudsonLady Davis Institute for Medical Research, Jewish General Hospital, 4333 Cote St Catherine Road, Montréal, Québec, H3T 1E4, Canada.
Murray BaronLady Davis Institute for Medical Research, Jewish General Hospital, 4333 Cote St Catherine Road, Montréal, Québec, H3T 1E4, Canada.
Brett D ThombsLady Davis Institute for Medical Research, Jewish General Hospital, 4333 Cote St Catherine Road, Montréal, Québec, H3T 1E4, Canada. brett.thombs@mcgill.ca.
and the Canadian Scleroderma Research Group
McGill University · CAJewish General Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fatigue is prevalent among patients with systemic sclerosis (SSc). To date, studies investigating fatigue in SSc have been hampered by the instruments used to measure fatigue in SSc and have included patient-reported rather than objectively-rated measures of disease. The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale is a validated measure for assessing fatigue in SSc that, compared to other instruments, provides good coverage of the full range of the fatigue spectrum. The objective of this study was to assess sociodemographic and objectively-rated disease-related associates of fatigue, as measured by the FACIT-F, in a large sample of patients with SSc. Fatigue was assessed using the FACIT-F scale. Disease severity was assessed using Medsger's severity scale. Multivariable linear regression was performed to assess the independent associations between sociodemographic and medical variables and fatigue. Among 785 patients, the mean FACIT-F score was 32.2 (SD = 12.1). Being age 40-49 (reference = 60+; standardized regression coefficient (β) = -0.11), less than post-secondary education (β = 0.07), having more medical comorbidities (β = -0.11) and more severe muscle (β = -0.10), gastrointestinal (β = -0.15), lung (β = -0.13), and general system disease severity (β = -0.13) were independently associated with more fatigue (p < 0.05). Fatigue in SSc was independently associated with more severe disease. These data contribute to a better understanding of fatigue in SSc and help inform patient-centered research in SSc.

Indexed as

AdolescentAdultAgedCanadaChronic DiseaseComorbidityFatigueFemaleHumansLinear ModelsMaleMiddle AgedMultivariate AnalysisRegistriesRheumatologyScleroderma, SystemicFACIT-FFatigueMedsger’s disease severity scaleSystemic sclerosis

Identifiers

PMID27943045
OpenAlexW2559782964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.